VYNE Therapeutics (VYNE) Tax Provisions (2019 - 2024)

VYNE Therapeutics' Tax Provisions history runs 5 years deep, the most recent figure standing at $4000.0 for Q4 2024.

• Quarterly Tax Provisions changed N/A year-over-year to $4000.0 in Q4 2024, while the trailing twelve-month figure through Mar 2026 was $4000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $4000.0, changed 0.0% from the prior year.
• Tax Provisions was $4000.0 for Q4 2024 at VYNE Therapeutics, down from $13000.0 in the prior quarter.
• Across five years, Tax Provisions topped out at $13000.0 in Q4 2022 and bottomed at -$448000.0 in Q4 2021.
• A 4-year average of -$137800.0 and a median of $1000.0 in 2020 frame the typical range for Tax Provisions.
• Peak annual rise in Tax Provisions reached 102.9% in 2022, while the deepest fall reached 102.9% in 2022.
• VYNE Therapeutics' Tax Provisions stood at $1000.0 in 2020, then tumbled by 44900.0% to -$448000.0 in 2021, then soared by 102.9% to $13000.0 in 2022, then sank by 69.23% to $4000.0 in 2024.
• Business Quant data shows VYNE's Tax Provisions at $4000.0 in Q4 2024, $13000.0 in Q4 2022, and -$448000.0 in Q4 2021.